Pharmapriser ApS: Financial statements 2025
CVR: 36479868
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Pharmapriser ApS (CVR 36479868) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -6,263 and a net result of DKK -8,073 compared with DKK -1,860 the year before. Equity in the 2025 report amounted to DKK 40,067. The solvency ratio was 100%.
- Gross Profit
- DKK -6,263
- Profit/Loss
- DKK -8,073
- Equity
- DKK 40,067
- Total Assets
- DKK 40,067
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -6 t. | -8 t. | 40 t. | - |
| 2024 | - | -1 t. | -2 t. | 48 t. | - |
| 2023 | 10 t. | -8 t. | -36 t. | -74 t. | - |
| 2022 | 87 t. | 17 t. | 17 t. | 105 t. | - |
| 2021 | 78 t. | 24 t. | 19 t. | -41 t. | - |
Official annual report
How creditworthy is Pharmapriser ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Pharmapriser ApS has published its annual report for 2024. Gross profit came to DKK -1,080, and the net result was DKK -1,860.
About Pharmapriser ApS
Pharmapriser ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2014. The company is registered under the industry Detailhandel med tøj. The company was previously named MAIN COPENHAGEN ApS. The management consists of Christian Frisch and Oscar Thalund-Jørgensen. The company is owned by JF Consolidated ApS. In 2025, the company reported a gross profit of DKK -6,263 and a net result of DKK -8,073 compared with DKK -1,860 the year before. Equity in the 2025 report amounted to DKK 40,067.